Browsing by Author "Willis, Mark"

Now showing items 1-1 of 1

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Kalincik, Tomas; Brown, J. William L.; Robertson, Neil; Willis, Mark; Scolding, Neil; Rice, Claire M.; Sola, Patrizia (Elsevier Science Inc, 2017)

Background Alemtuzumab, an anti-CD52 antibody, is proven to be more efficacious than interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis, but its efficacy relative to more potent immunotherapies ...